N
Nobuo Hiwatashi
Researcher at Tohoku University
Publications - 135
Citations - 3827
Nobuo Hiwatashi is an academic researcher from Tohoku University. The author has contributed to research in topics: Crohn's disease & Ulcerative colitis. The author has an hindex of 36, co-authored 135 publications receiving 3655 citations.
Papers
More filters
Journal ArticleDOI
Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.
Takashi Shimoyama,Koji Sawada,Nobuo Hiwatashi,Toshio Sawada,Kei Matsueda,Akihiro Munakata,Hitoshi Asakura,Takao Tanaka,Reiji Kasukawa,Ken Kimura,Yasuo Suzuki,Yukio Nagamachi,Tetsuichiro Muto,Hirokazu Nagawa,Bunei Iizuka,Shozo Baba,Masaru Nasu,Tatsuji Kataoka,Nobuhito Kashiwagi,Abby R. Saniabadi +19 more
TL;DR: Based on the results, it is believed that in patients with active severe UC, patients who are refractory to conventional drugs, granulocyte and monocyte adsorption apheresis is a useful adjunct to conventional therapy.
Journal ArticleDOI
Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial.
Sho Takagi,K. Utsunomiya,Shinichi Kuriyama,Hiroshi Yokoyama,S. Takahashi,Masahiro Iwabuchi,H. Takahashi,Yoshitaka Kinouchi,Nobuo Hiwatashi,Yuji Funayama,Iwao Sasaki,Ichiro Tsuji,Toru Shimosegawa +12 more
TL;DR: Although thiopurines have a proven role in maintenance therapy for Crohn's disease, an alternative therapy is needed for patients intolerant or resistant to thiopirines.
Journal ArticleDOI
Crohn's disease in Japan: diagnostic criteria and epidemiology.
TL;DR: Clinically, Crohn's disease with only multiple small aphthous ulcerations, which is the earliest stage of the disease that is diagnosable, was found in 5 percent of patients.
Journal ArticleDOI
Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene
Kenichi Negoro,Yoshitaka Kinouchi,Nobuo Hiwatashi,Seiichi Takahashi,Sho Takagi,Jo Satoh,Tooru Shimosegawa,Takayoshi Toyota +7 more
TL;DR: Although the findings need to be confirmed in other populations with larger numbers of patients, TNF gene polymorphisms -1031C, -863A, and -857T are positively associated with CD; they may influence not only the susceptibility to CD but also the disease location.
Journal ArticleDOI
Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.
Koji Sawada,Tetsuichiro Muto,Takashi Shimoyama,Masamichi Satomi,Toshio Sawada,Hirokazu Nagawa,Nobuo Hiwatashi,Hitoshi Asakura,Toshifumi Hibi +8 more
TL;DR: The results of the trial show that LCAP permits a reduction in total PSL dosage and is more effective and safer than high-dose PSL administration for intensive therapy, and LCAP may maintain remission longer than PSL.